Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Verastem, Inc.(VSTM) | 3,302,300 | 3,349,627 | +47,327 | $17.50M | $12.80M | 9.74% | -$4.71M |
| Evolus, Inc.(EOLS) | 1,759,091 | 1,590,162 | -168,929 | $7.23M | $11.04M | 8.40% | +$3.81M |
| Tenax Therapeutics, Inc.(TENX) | 975,200 | 660,000 | -315,200 | $15.59M | $9.60M | 7.31% | -$5.99M |
| Nektar Therapeutics(NKTR) | 85,000 | 120,654 | +35,654 | $6.12M | $8.42M | 6.41% | +$2.31M |
| Adma Biologics Inc | 740,000 | 740,000 | 0 | $6.67M | $6.19M | 4.72% | -$473.6K |
| CAMP4 THERAPEUTICS CORPORATIONCOM 13469V AB 4 CAMTEK LTD NOTE 12 0(CAMP) | 1,389,622 | 1,389,622 | 0 | $6.13M | $6.07M | 4.62% | -$55.6K |
| Eloxx Pharmaceuticals Inc | 0 | 397,160 | +397,160 | $0 | $5.51M | 4.20% | +$5.51M |
| Kazia Therapeutics LimitedADS(KZIA) | 345,179 | 345,179 | 0 | $2.57M | $4.86M | 3.70% | +$2.29M |
| Indivior Pharmaceuticals, Inc.(INDV) | 0 | 100,000 | +100,000 | $0 | $4.10M | 3.12% | +$4.10M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 383,462 | 425,000 | +41,538 | $3.60M | $3.99M | 3.03% | +$385.8K |
| Satellos Bioscience Inc.(MSLE) | 100,000 | 491,624 | +391,624 | $563.0K | $3.72M | 2.83% | +$3.16M |
| Zevra Therapeutics, Inc.(ZVRA) | 480,000 | 258,701 | -221,299 | $4.47M | $3.71M | 2.82% | -$763.8K |
| Abeona Therapeutics Inc.(ABEO) | 746,587 | 557,284 | -189,303 | $3.34M | $3.44M | 2.62% | +$99.3K |
| Edesa Biotech, Inc.(EDSA) | 30,000 | 456,439 | +426,439 | $156.9K | $3.19M | 2.43% | +$3.03M |
| Cabaletta Bio, Inc.(CABA) | 50,000 | 917,100 | +867,100 | $134.5K | $2.85M | 2.17% | +$2.72M |
| An2 Therapeutics Inc | 713,845 | 551,692 | -162,153 | $2.44M | $2.67M | 2.03% | +$228.8K |
| Xilio Therapeutics, Inc.(XLO) | 64,162 | 225,994 | +161,832 | $539.6K | $2.17M | 1.65% | +$1.63M |
| Adicet Bio Inc | 221,955 | 245,518 | +23,563 | $1.51M | $2.12M | 1.61% | +$609.8K |
| TELA Bio, Inc.(TELA) | 2,617,252 | 2,662,427 | +45,175 | $1.62M | $2.00M | 1.52% | +$374.1K |
| Aytu Biopharma Inc | 792,289 | 912,921 | +120,632 | $2.16M | $1.96M | 1.49% | -$200.2K |
| Curis, Inc.(CRIS) | 3,726,406 | 3,312,185 | -414,221 | $2.04M | $1.73M | 1.32% | -$310.2K |
| Spruce Biosciences Inc | 0 | 28,795 | +28,795 | $0 | $1.55M | 1.18% | +$1.55M |
| OKYO Pharma LimitedSHS NEW(OKYO) | 850,000 | 862,996 | +12,996 | $1.37M | $1.29M | 0.99% | -$74.0K |
| Pasithea Therapeutics Corp.(KTTA) | 831,301 | 2,201,468 | +1,370,167 | $616.7K | $1.13M | 0.86% | +$518.0K |
| Sol-Gel Technologies LtdSHS NEW SHS NEW | 27,778 | 14,469 | -13,309 | $2.20M | $1.07M | 0.82% | -$1.13M |
| Pulmonx Corporation(LUNG) | 768,288 | 815,436 | +47,148 | $991.1K | $1.06M | 0.81% | +$69.0K |
| X4 Pharmaceuticals, Inc.(XFOR) | 335,309 | 224,989 | -110,320 | $1.38M | $1.05M | 0.80% | -$334.1K |
| In8bio Inc | 663,412 | 695,287 | +31,875 | $981.9K | $980.4K | 0.75% | -$1.5K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 0 | 50,000 | +50,000 | $0 | $973.5K | 0.74% | +$973.5K |
| Quoin Pharmaceuticals, Ltd.ADS(QNRX) | 53,460 | 199,486 | +146,026 | $352.8K | $965.5K | 0.74% | +$612.7K |
| MaxCyte, Inc.(MXCT) | 1,004,673 | 751,606 | -253,067 | $705.8K | $924.5K | 0.70% | +$218.7K |
| Phathom Pharmaceuticals, Inc.(PHAT) | 50,010 | 85,010 | +35,000 | $555.6K | $922.4K | 0.70% | +$366.7K |
| Azitra, Inc.(AZTR) | 0 | 5,285,476 | +5,285,476 | $0 | $886.9K | 0.68% | +$886.9K |
| Connect Biopharma Holdings LimitedSHS(CNTB) | 310,000 | 364,254 | +54,254 | $812.2K | $866.9K | 0.66% | +$54.7K |
| Cybin D/B/A Helus Pharma(HELP) | 134,060 | 129,280 | -4,780 | $643.5K | $854.5K | 0.65% | +$211.1K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 25,000 | +25,000 | $0 | $834.8K | 0.64% | +$834.8K |
| Inhibikase Therapeutics, Inc.(IKT) | 957,202 | 396,179 | -561,023 | $1.61M | $804.2K | 0.61% | -$803.9K |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 269,100 | 161,583 | -107,517 | $629.7K | $783.7K | 0.60% | +$154.0K |
| CytomX Therapeutics, Inc.(CTMX) | 200,000 | 205,000 | +5,000 | $940.0K | $768.8K | 0.59% | -$171.3K |
| Nuvectis Pharma, Inc.(NVCT) | 0 | 40,000 | +40,000 | $0 | $735.6K | 0.56% | +$735.6K |
| Crescent Biopharma, Inc.(CBIO) | 85,000 | 40,000 | -45,000 | $1.56M | $720.0K | 0.55% | -$841.5K |
| PMV Pharmaceuticals, Inc.(PMVP) | 708,102 | 536,086 | -172,016 | $878.0K | $718.4K | 0.55% | -$159.7K |
| Oruka Therapeutics, Inc.(ORKA) | 0 | 7,500 | +7,500 | $0 | $713.8K | 0.54% | +$713.8K |
| Radiopharm Theranostics LimitedADS(RADX) | 51,000,000 | 51,000,000 | 0 | $739.0K | $670.5K | 0.51% | -$68.5K |
| OnKure Therapeutics, Inc.CL A(OKUR) | 132,578 | 130,684 | -1,894 | $548.9K | $595.9K | 0.45% | +$47.0K |
| NervGen Pharma Corp.(NGEN) | 0 | 271,678 | +271,678 | $0 | $559.7K | 0.43% | +$559.7K |
| CalciMedica, Inc.(CALC) | 0 | 622,432 | +622,432 | $0 | $544.9K | 0.41% | +$544.9K |
| Arvinas, Inc.(ARVN) | 27,500 | 60,000 | +32,500 | $291.5K | $498.6K | 0.38% | +$207.1K |
| BioAge Labs, Inc.(BIOA) | 50,000 | 20,000 | -30,000 | $874.5K | $490.2K | 0.37% | -$384.3K |
| Opus Genetics, Inc.(IRD) | 68,688 | 100,718 | +32,030 | $312.5K | $414.0K | 0.32% | +$101.4K |
| QT Imaging Holdings, Inc.(QTI) | 0 | 100,000 | +100,000 | $0 | $407.0K | 0.31% | +$407.0K |
| Boundless Bio, Inc.(BOLD) | 597,682 | 154,595 | -443,087 | $657.5K | $386.5K | 0.29% | -$271.0K |
| Sintx Technologies, Inc.(SINT) | 0 | 209,205 | +209,205 | $0 | $332.5K | 0.25% | +$332.5K |
| Cellectar Biosciences, Inc.(CLRB) | 0 | 104,550 | +104,550 | $0 | $290.6K | 0.22% | +$290.6K |
| Eupraxia Pharmaceuticals Inc.COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0 750 3 1(EPRX) | 0 | 43,491 | +43,491 | $0 | $287.5K | 0.22% | +$287.5K |
| SAB Biotherapeutics, Inc.(SABS) | 50,000 | 73,271 | +23,271 | $191.5K | $285.8K | 0.22% | +$94.3K |
| Adlai Nortye Group Ltd.ADS(ANL) | 0 | 24,257 | +24,257 | $0 | $279.0K | 0.21% | +$279.0K |
| Senseonics Holdings, Inc.(SENS) | 0 | 48,680 | +48,680 | $0 | $276.5K | 0.21% | +$276.5K |
| Pliant Therapeutics, Inc.(PLRX) | 224,650 | 230,538 | +5,888 | $283.1K | $262.8K | 0.20% | -$20.2K |
| Codexis, Inc.(CDXS) | 417,994 | 109,662 | -308,332 | $681.3K | $247.8K | 0.19% | -$433.5K |
| Precision Optics Corporation, Inc.(POCI) | 100,000 | 46,390 | -53,610 | $439.0K | $236.6K | 0.18% | -$202.4K |
| Upstream Bio, Inc.(UPB) | 35,000 | 33,432 | -1,568 | $315.0K | $231.3K | 0.18% | -$83.7K |
| Rein Therapeutics Inc.(RNTX) | 0 | 218,038 | +218,038 | $0 | $226.8K | 0.17% | +$226.8K |
| Heron Therapeutics, Inc.(HRTX) | 1,402,191 | 490,787 | -911,404 | $1.12M | $209.5K | 0.16% | -$912.4K |
| CNS Pharmaceuticals, Inc.(CNSP) | 61,000 | 41,573 | -19,427 | $145.8K | $198.7K | 0.15% | +$52.9K |
| Humacyte, Inc.(HUMA) | 0 | 231,299 | +231,299 | $0 | $180.5K | 0.14% | +$180.5K |
| Kalaris Therapeutics, Inc.(KLRS) | 20,400 | 30,122 | +9,722 | $117.7K | $122.6K | 0.09% | +$4.9K |
| Processa Pharmaceuticals, Inc.(PCSA) | 55,000 | 55,000 | 0 | $138.9K | $105.6K | 0.08% | -$33.3K |
| BioAtla, Inc.(BCAB) | 0 | 16,432 | +16,432 | $0 | $68.0K | 0.05% | +$68.0K |
| Compugen Ltd.(CGEN) | 104,300 | 31,387 | -72,913 | $222.2K | $67.2K | 0.05% | -$155.0K |
| Ovid Therapeutics Inc.(OVID) | 40,000 | 21,300 | -18,700 | $88.8K | $57.3K | 0.04% | -$31.5K |
| Evaxion A/SADS(EVAX) | 19,713 | 17,562 | -2,151 | $73.3K | $54.4K | 0.04% | -$18.9K |
| BioAtla, Inc.(BCAB) | 65,387 | 0 | -65,387 | $10.5K | $0 | — | -$10.5K |
| Candel Therapeutics, Inc.(CADL) | 102,500 | 0 | -102,500 | $502.3K | $0 | — | -$502.3K |
| Eledon Pharmaceuticals, Inc.(ELDN) | 35,000 | 0 | -35,000 | $107.8K | $0 | — | -$107.8K |
| Establishment Labs Holdings Inc.(ESTA) | 6,000 | 0 | -6,000 | $340.7K | $0 | — | -$340.7K |
| Janux Therapeutics, Inc.(JANX) | 20,000 | 0 | -20,000 | $278.0K | $0 | — | -$278.0K |
| MannKind Corporation(MNKD) | 16,300 | 0 | -16,300 | $39.9K | $0 | — | -$39.9K |
| Neumora Therapeutics, Inc.(NMRA) | 100,000 | 0 | -100,000 | $195.0K | $0 | — | -$195.0K |
| OmniAb, Inc.(OABI) | 164,045 | 0 | -164,045 | $257.6K | $0 | — | -$257.6K |
| SI-BONE, Inc.(SIBN) | 14,964 | 0 | -14,964 | $189.0K | $0 | — | -$189.0K |
| Surrozen, Inc.(SRZN) | 33,005 | 0 | -33,005 | $961.4K | $0 | — | -$961.4K |
| Verrica Pharmaceuticals Inc.(VRCA) | 99,735 | 0 | -99,735 | $527.6K | $0 | — | -$527.6K |
| Xeris Biopharma Holdings Inc | 40,030 | 0 | -40,030 | $232.2K | $0 | — | -$232.2K |
| Xoma Royalty Corporation | 69,500 | 0 | -69,500 | $2.18M | $0 | — | -$2.18M |